Press release
Interstitial Cystitis Global Market Size $2.53 Billion Revenue By 2028 Growing Rapidly with Recent Trends and Outlook
"The new report published by The Business Research Company, titled Interstitial Cystitis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.As per the report, the interstitial cystitis market size has grown strongly in recent years. It will grow from $1.69 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The interstitial cystitis market size is expected to see strong growth in the next few years. It will grow to $2.53 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13041&type=smp
Surging Urinary Tract Infections Fuel Growth In The Interstitial Cystitis Market
The rising prevalence of urinary tract infections is expected to propel the growth of the interstitial cystitis market. Urinary tract infections are bacterial infections that can occur anywhere in the urinary system and are caused by bacteria that enter the urethra. UTI can induce bacterial cystitis directly or indirectly and untreated UTI can lead to persistent bladder inflammation, the underlying cause of interstitial cystitis. Treatment for urinary tract infections caused by interstitial cystitis improves pain alleviation and quality of life in patients suffering from the disease. For instance, in 2021, according to the Centers for Disease Control and Prevention, a US-based national public health agency, in the US there were around 24,710 catheter-associated urinary tract infections reported in 2021. Further, according to an article published by The British Society for Antimicrobial Chemotherapy, a UK-based multi-professional organization, estimated that almost half of all women in the United Kingdom will get at least one urinary tract infection (UTI) at some point in their lives. Therefore, the rising prevalence of urinary tract infections drives the interstitial cystitis market.
Innovative Intravesical Solutions Revolutionize Interstitial Cystitis Treatment Market
Major companies operating in the interstitial cystitis treatment market are focused on developing innovative products, such as intravesical solutions, to treat interstitial cystitis and drive revenues in the market. Innovative treatments, such as interstitial cystitis intravesical solution, enhance the care and outcomes of this chronic and frequently complex bladder illness. For instance, in April 2021, Kyorin Pharmaceutical Co Ltd., a Japan-based developer and manufacturer of prescription medicines and quasi-drugs, launched Interstitial cystitis Zymso Intravesical Solution 50%, a dimethyl sulfoxide (DMSO) bladder instillation. It is uniquely designed with DMSO. Zymso is injected into the bladder through a catheter intended to relieve pain and discomfort associated with IC. The dosage for adults is six injections of 50 mL of 50% (w / w) dimethyl sulfoxide solution (27g of dimethyl sulfoxide) into the bladder spaced by two weeks.
The interstitial cystitis market covered in this report is segmented -
1) By Treatment: Medications; Bladder Instillation; Botulinum Toxin A; Nerve Stimulation; Surgery
2) By Patient Type: Pediatric Patients; Adult Patients
3) By Drug Type: Over-The-Counter (OTC) Drugs; Prescription Drugs
4) By End User: Hospitals And Clinics; Homecare
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13041&type=discount
Major players in the interstitial cystitis market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim international GmbH, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Perrigo Company PLC, Aurobindo Pharma Ltd., Purdue Pharma LP, Apotex Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Alvogen Inc., Kyorin Pharmaceutical Co. Ltd., Seikagaku Corp, Genentech Inc., Strides Pharma Science Limited, AlgoTherapeutix SAS.
Contents of the report:
1. Executive Summary
2. Interstitial Cystitis Market Report Structure
3. Interstitial Cystitis Market Trends And Strategies
4. Interstitial Cystitis Market - Macro Economic Scenario
5. Interstitial Cystitis Market Size And Growth
…..
27. Interstitial Cystitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/interstitial-cystitis-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Interstitial Cystitis Global Market Size $2.53 Billion Revenue By 2028 Growing Rapidly with Recent Trends and Outlook here
News-ID: 3619676 • Views: …
More Releases from The Business research company
Leading Companies Solidify Their Presence in the Silicone Structural Glazing Mar …
The silicone structural glazing market is positioned for significant expansion in the coming years, driven by advances in building technology and increased environmental awareness. This sector is evolving rapidly as demand grows for more energy-efficient and aesthetically appealing architectural solutions. Let's explore the market's current size, key players, emerging trends, and the main segments that are shaping its future.
Silicone Structural Glazing Market Value Forecast Through 2030
The market for silicone…
Future Prospects: Key Trends Shaping the Self-Healing Concrete Market up to 2030
The self-healing concrete market is capturing significant attention as innovations and sustainability demands rise in construction. This sector is set to experience remarkable growth due to advancements in materials and technology, shaping the future of durable and intelligent infrastructure solutions. Let's explore the market's size, key players, emerging trends, and segment outlook to understand its trajectory.
Projected Market Size and Growth Prospects for the Self-Healing Concrete Market
The self-healing concrete market…
Analysis of Key Market Segments Driving the ROS-Based Robot Industry
The ROS-based robot market is positioned for substantial growth as robotics technology continues to advance rapidly. With increasing innovation in software, hardware, and AI integration, this sector is set to transform multiple industries by 2030. Below, we explore the market's future size, leading companies, key trends, and segmentation details to understand its evolving landscape.
Projected Market Size and Expansion of the ROS-Based Robot Market
The ROS-based robot market is anticipated to…
Global Trends Overview: The Rapid Evolution of the Robotic Panelized Home Builde …
The robotic panelized home builder market is positioned for impressive growth in the coming years as automation and robotics increasingly transform construction processes. Driven by technological advancements and expanding prefab housing projects, this market is set to reshape how homes are built with greater speed and efficiency. Let's explore the market's size, leading companies, emerging trends, and key segments that are shaping its future.
Strong Growth Forecast for the Robotic Panelized…
More Releases for Interstitial
Prominent Interstitial Cystitis Market Trend for 2025: Advancements in Interstit …
How Are the key drivers contributing to the expansion of the interstitial cystitis market?
The increasing occurrence of urinary tract infections is anticipated to fuel the expansion of the interstitial cystitis market. Urinary tract infections are bacterial infections that can materialize at any point in the urinary system, resulting from bacteria that infiltrate the urethra. These infections could directly or indirectly bring about bacterial cystitis, and lack of treatment can lead…
Shaping the Interstitial Cystitis Market in 2025: Advancements in Interstitial C …
How Big Is the Interstitial Cystitis Market Expected to Be, and What Will Its Growth Rate Be?
The interstitial cystitis market is projected to grow from $1.83 billion in 2024 to $1.98 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. This growth is attributed to advancements in diagnosis, increased awareness and education, pharmaceutical developments, and supportive therapies.
The Interstitial Cystitis market will grow to $2.78 billion by 2029…
Prominent Interstitial Lung Disease Market Trend for 2025: Innovative Drug Devel …
What Are the Projected Growth and Market Size Trends for the Interstitial Lung Disease Market?
The interstitial lung disease market is expected to grow from $1.97 billion in 2024 to $2.11 billion in 2025, at a CAGR of 7.2%. Growth drivers include improved awareness and diagnosis, immune system modulation therapies, respiratory rehabilitation programs, and multidisciplinary care teams.
The Interstitial Lung Disease market will grow to $2.85 billion by 2029 at a CAGR…
Interstitial lung disease Pipeline involves 120+ key companies continuously work …
DelveInsight's, "Interstitial Lung Diseases Pipeline Insight, 2022," report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Interstitial Lung Disease…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs.
Download the sample report @ https://www.pharmaproff.com/request-sample/1126
The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues.
Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis
Some of the types of the condition include…
